Mingzhao Li
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Do all patients need a urethral catheter after robotic-assisted radical prostatectomy?
Journal: Journal of robotic surgery
Published: March 10, 2026
Extraperitoneal single-site robot-assisted radical prostatectomy with extended pelvic lymph node dissection: technique and experience.
Journal: BJU international
Published: January 31, 2025
Intriguing future: single-site robotic-assisted radical prostatectomy.
Journal: Chinese clinical oncology
Published: September 10, 2024
Short-term urinary continence outcomes after extraperitoneal single-site robot-assisted radical prostatectomy: A retrospective study.
Journal: Asian journal of urology
Published: August 13, 2024
First-in-human study of dosimetry, safety and efficacy for [177Lu]Lu-P15-073: a novel bisphosphonate-based radioligand therapy (RLT) agent for bone metastases.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 16, 2024
First-in-human study of PSMA-targeting agent, [18F]AlF-P16-093: dosimetry and initial evaluation in prostate cancer patients.
Journal: European journal of nuclear medicine and molecular imaging
Published: October 19, 2023
Association between 3D membranous urethral parameters and urinary continence recovery after RARP.
Journal: European journal of medical research
Published: August 11, 2023
Adverse effect of environmental androgenic compounds Galaxolide and Irgacure 369 on the male reproductive system.
Journal: Reproductive toxicology (Elmsford, N.Y.)
Published: July 24, 2023
Galaxolide and Irgacure 369 are novel environmental androgens.
Journal: Chemosphere
Published: January 10, 2023
GTSE1 promotes prostate cancer cell proliferation via the SP1/FOXM1 signaling pathway.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: June 07, 2020
Methylcrotonoyl-CoA Carboxylase 2 Promotes Proliferation, Migration and Invasion and Inhibits Apoptosis of Prostate Cancer Cells Through Regulating GLUD1-P38 MAPK Signaling Pathway.
Journal: OncoTargets and therapy
Published: February 15, 2020
SPAG9 promotes prostate cancer proliferation and metastasis via MAPK signaling pathway.
Journal: American journal of translational research
Published: January 24, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026